Literature DB >> 14529226

A 3-year review of neurologic admissions in University College Hospital Ibadan, Nigeria.

O A Talabi1.   

Abstract

A 3 year review of neurologic admissions into the adult medical wards at the UCH, Ibadan, Nigeria between January 1998 and December 2000 is presented. The study design involved the scrutiny of the records of all the neurological admissions, male and female to the medical ward. The identified cases were then classified and only cases confirmed as neurological were further analysed. Stroke, predominantly non-hemorrhagic accounted for 50.4% of cases for the period of study. Stroke is therefore the most common cause of adult neurologic admissions on medical wards of UCH. Central nervous system infections, comprising mainly of tetanus and meningitis accounted for 14.2% (111) and 12.4% (97) of case respectively. The myelopathies were the cause of neurologic admissions in 8.1% (63) of cases followed by seizure disorders. Headache was the reason for admission in 0.9% (7) of cases. Parkinsons disease, hypertensive encephalopathy, Guillian Barne syndrome, seasonal ataxic neuropathy, cavernous sinus thrombophlebitis, normal pressure hydrocephalus were rarely the cause of admission. Similarly, dystonia, and cerebral malaria recorded 0.13% (1) of cases each. A case is made for the establishment of regional stroke units in Nigeria.

Entities:  

Mesh:

Year:  2003        PMID: 14529226     DOI: 10.4314/wajm.v22i2.27937

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  11 in total

Review 1.  Parkinson's disease in Nigeria: A review of published studies and recommendations for future research.

Authors:  Oluwafemi G Oluwole; Helena Kuivaniemi; Jonathan A Carr; Owen A Ross; Matthew O B Olaogun; Soraya Bardien; Morenikeji A Komolafe
Journal:  Parkinsonism Relat Disord       Date:  2018-12-08       Impact factor: 4.891

2.  Neuroinfection survey at a neurological ward in a Brazilian tertiary teaching hospital.

Authors:  Paulo E Marchiori; Angelina M M Lino; Luis R Machado; Livia M Pedalini; Marcos Boulos; Milberto Scaff
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Pattern of neurological admissions in the tropics: Experience at Kano, Northwestern Nigeria.

Authors:  L F Owolabi; M Y Shehu; M N Shehu; J Fadare
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

4.  Utilization of physiotherapy in the continuum of stroke care at a tertiary hospital in Ibadan, Nigeria.

Authors:  Olubukola Adebisi Olaleye; Zainab Iyabo Lawal
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

5.  Non-glaucomatous optic neuropathy in ibadan: extrapolations to healthcare funding in Nigeria.

Authors:  O A Ogun; O A Adediran
Journal:  Ann Ib Postgrad Med       Date:  2014-12

6.  Factors associated with death and predictors of one-month mortality from stroke in Kano, Northwestern Nigeria.

Authors:  Owolabi Lukman Femi; Nagoda Mansur
Journal:  J Neurosci Rural Pract       Date:  2013-08

7.  Stroke Impact Scale 3.0: Reliability and Validity Evaluation of the Korean Version.

Authors:  Seong Uk Choi; Hye Sun Lee; Joon Ho Shin; Seung Hee Ho; Mi Jung Koo; Kyoung Hae Park; Jeong Ah Yoon; Dong Min Kim; Jung Eun Oh; Se Hwa Yu; Dong A Kim
Journal:  Ann Rehabil Med       Date:  2017-06-29

8.  Influence of Sociodemographic and Stroke-related Factors on Availability of Social Support among Nigerian Stroke Survivors.

Authors:  G O Vincent-Onabajo; M M Muhammad; M Usman Ali; M Ali Masta
Journal:  Ann Med Health Sci Res       Date:  2015 Sep-Oct

9.  Pattern of in-patient neurologic review: An experience from a Tertiary Hospital North-Western Nigeria.

Authors:  Aliyu Ibrahim; Lukman Femi Owolabi; Baba Maiyaki Musa; Salisu Aliyu; Musbahu Rabiu; Ahmed Maifada Yakasai
Journal:  Ann Afr Med       Date:  2016 Apr-Jun

Review 10.  Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care.

Authors:  Uduak Williams; Oliver Bandmann; Richard Walker
Journal:  J Mov Disord       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.